Besim Ogretmen, Ph.D. (IMAGE)

Medical University of South Carolina

Besim Ogretmen, Ph.D.

Caption

Dr. Besim Ogretmen is hopeful that research into mitochondrial targeting will lead to a new class of cancer drugs. File photo

Credit

Medical University of South Carolina

Usage Restrictions

Use with credit to MUSC

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.